534 results on '"Mouly, V"'
Search Results
52. Analysis of the autophagic pathway during in vitro muscle differentiation in X-linked myopathy with excessive autophagy
53. In vitro activation of type I interferon pathway reproduces the characteristics damages observed in dermatomyositis patients
54. DUX 4 and DUX4 downstream target genes are expressed in fetal FSHD muscles
55. On the analysis of induction motor with square wave currents in the rotor via state transition signal flow graph technique
56. Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient A Cellular Model for FSHD
57. The Rag2-/-Il2rb-/-Dmd-/- mouse model: a new kick-off for human myogenic stem cells transplantation
58. Correlation between low FAT1 expression and early affected muscle in FSHD
59. Reversible immortalization allows human artificial chromosome-mediated gene correction of human dystrophic muscle progenitor cells
60. Engineering human 3D micromuscles with co-culture of fibroblasts and myoblasts
61. TH.O.15 - Gene therapy for oculopharyngeal muscular dystrophy
62. P.300 - Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR/Cas9 system
63. G.O.5
64. O01 Autologous cell therapy in oculopharyngeal muscular dystrophy (OPMD)
65. Age-dependent alteration in muscle regeneration: the critical role of tissue niche.
66. Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients
67. Regenerative potential of human muscle stem cells in chronic inflammation
68. P.361 - Analysis of the autophagic pathway during in vitro muscle differentiation in X-linked myopathy with excessive autophagy
69. P.196 - In vitro activation of type I interferon pathway reproduces the characteristics damages observed in dermatomyositis patients
70. P.16.12 OPMD from the myoblast’s and fibroblast’s point of view
71. P.16.3 DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles
72. G.P.106 Immunohistochemical study of cricopharyngeal muscle in oculopharyngeal muscular dystrophy
73. P07 Meganuclease-enhanced genome correction therapy for Duchenne muscular dystrophy
74. O.12 Studies in antisense oligonucleotide induced exon skipping of single or double exon duplications
75. P5.28 Culture supernatants from HTLV-1 infected T cells modify adhesion molecule-related gene signature in differentiated human muscle
76. P1.47 CD49d is a disease biomarker and a potential therapeutic target in Duchenne muscular dystrophy
77. P4.33 Rapid differentiation of engrafted human myoblasts into immunodeficient mice correlates with the reduced proliferation and migration
78. P5.79 Differential mRNA expression in differentiation of human myogenic precursors: Correlation with the microRNA pattern
79. P2.45 Proteomic studies of muscle progenitor cells in affected and non-affected oculopharyngeal muscular dystrophy muscles
80. Satellite cells and training in the elderly.
81. G.O.15 - Correlation between low FAT1 expression and early affected muscle in FSHD
82. G.P.218 - Reversible immortalization allows human artificial chromosome-mediated gene correction of human dystrophic muscle progenitor cells
83. T.P.1.09 Oculopharyngeal muscular dystrophy (OPMD): Physiopathological mechanisms and gene therapy approaches
84. Barriers and opportunities to recruitment in mental health: the case of New Zealand
85. D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts
86. D.P.4.05 CTG expansions in relation to symptoms and muscle histopathology in DM1 patients
87. Regenerative capacity of human satellite cells : the mitotic clock in cell transplantation
88. G.P.3.01 The use of immortalised human fibroblasts from a DMD patient to test exon skipping in vivo
89. G.P.7.14 Protocol of autologous myoblast transplantation in the pharyngeal muscles to correct dysphagia in patients with oculopharyngeal muscular dystrophy
90. G.P.16.08 CTGF regulation during myogenesis in vitro: Effect of CTGF on myogenic cells
91. G.P.16.10 In vivo myogenic potential of human AC133 muscle-derived stem cells
92. G.P.16.01 Human cellular models for muscular disorders as tools to study pathophysiology and to develop therapeutic approaches
93. Autologous Transplantation of Muscle-Derived CD133+ Stem Cells in Duchenne Muscle Patients
94. Deregulation and industrial change: A comparative study of the electricity sectors of New Zealand and the Gambia
95. Myogenic stem cells: regeneration and cell therapy in human skeletal muscle
96. L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains
97. Extended AmplificationIn Vitroand Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation
98. G.O.5: Mitochondrial dysfunction reveals defective poly(A) tail regulation of specific mRNAs as a primary defect in oculopharyngeal muscular dystrophy
99. A New Immunodeficient Mouse Model for Human Myoblast Transplantation
100. Regenerative capacity of human satellite cells: the mitotic clock in cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.